Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forum
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forum
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post Job
Jobs posted by me
Users & Profiles
News
Login/Register
Tag:
CFR Part 11
Warning letter / Medgel / July 2023 /Lap
Medgel, India was issued a Warning letter by USFDA in July 2023. Deficiencies include inadequate
Qvents
August 23, 2023
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
USFDA 483 to Laurus: Lapses in cleaning, documentation.
June 16, 2025
Aarti Drugs USFDA 483 Flags Unique Challenges of Generic Pharma Companies
June 16, 2025
Yiling Pharma Warning Letter: Equipment Duct Cleaning & Cross-Contamination Issues Flagged
June 14, 2025
Trial
June 13, 2025
Life Style
May 9, 2025